Excelsior Sciences

👥 22 employees💰 Last funded Dec 2025

Biotechnology Research 🌐 excelsiorsci.com

At Excelsior Sciences we are revolutionizing small molecule innovation by developing a new form of chemistry that machines can do and AI can use to accelerate the discovery and manufacture of small molecules. Our unique smart blocc approach quickly creates molecular solutions from automated synthesis-friendly, function-infused and AI-readable building blocks. These smart bloccs serve as tokens in a modular chemical “language” that enables AI to accelerate discovery and manufacturing, derive novel insights and define new functional frontiers for an array of industries and applications. We are the only company built on a proven, published track record of making real-world advances in multiple fields using automated small molecule synthesis coupled with AI, with the goal to spark an innovation renaissance of safer, more effective and more sustainable solutions to human and planetary challenges.

Total investors

Early stage

Mid stage

Late stage

—

Founded